Century Therapeutics share price logo

Century Therapeutics

NASDAQ: IPSC

Small Cap

$1.65

-0.02

(-1.20%)

as on

Century Therapeutics Stock Performance

as on September 30, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.63
    $1.67
    downward going graph

    1.21%

    Downside

    1.21%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.44
    $3.04
    downward going graph

    73.64%

    Downside

    84.24%

    Upside

    downward going graph

Century Therapeutics share price movements today

Previous Close
$1.67
Open
$1.67
Volume
566.0K
Market Cap
$302.4M
Day's Low - High
$1.63 - $1.67
52 Week Low - High
$0.44 - $3.04

Century Therapeutics Historical Returns

1 Month Return
-18.52 %
3 Month Return
-32.65 %
1 Year Return
+ 231.33 %
3 Year Return
-17.5 %
5 Year Return
-93.44 %

Century Therapeutics Stock Fundamentals & Key Indicators

Check Century Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$302.4M

EPS (TTM)

-1.04

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.61

Industry PE ratio

-8.70

PEG Ratio

0.00

EBITDA

-95.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-52.76%

Century Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Century Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$302.4M-93.44%-1.610.00%0.00%
StrongBuy$43.2B643.29%-22.770.00%0.00%
Neutral$78.8B-47.13%-24.72-12.57%0.00%
StrongBuy$133.4B189.75%30.3886.04%0.00%
Buy$81.1B24.01%17.9684.86%0.49%

Stock Returns calculator for Century Therapeutics Stock including INR - Dollar returns

The Century Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Century Therapeutics investment value today

Current value as on today

₹3,58,502

Returns

₹2,58,502

(+258.5%)

Returns from Century Therapeutics Stock

₹2,31,325 (+231.33%)

Dollar Impact

₹27,177 (+27.18%)

Analyst Recommendation on Century Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Century Therapeutics. Average target price of $4.75

Century Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Century Therapeutics.

What analysts predicted

65.26%UPSIDE

Target Price

$4.75

Current Price

$1.65

Analyzed by

2 Analysts

High

$5

Target

$4.75

Low

$5

Century Therapeutics target price $4.75, a slight upside of 65.26% compared to current price of $1.65. According to 2 analysts rating.

Indian Investors' Interest in Century Therapeutics Stock

Search interest for Century Therapeutics Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Century Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
4
109
-
-
-
-
-
Gross Profit
0
0
0
4
109
-26
-22
-
-3
-
Operating Income
-31
-34
-34
-37
74
-34
-36
-20
-25
-36
EBITDA
-24
-27
-27
-30
79
-29
-26
-15
-18
-34
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
3
3
3
3
3
3
3
3
3
0
Income Before Tax
-28
-31
-31
-34
76
-32
-34
-19
-21
-34
Income Tax Expense
0
0
0
1
-
-
-
0
-
-
Net Income
-28
-31
-31
-36
76
-32
-34
-19
-21
-34
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Century Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
5
2
6
109
Gross Profit
0
-1
-4
5
2
6
96
Operating Income
-20
-49
-94
-133
-146
-138
-15
EBITDA
-244
-51
-89
-121
-121
-111
3
Interest Expense
-
0
1
-
0
-
-
Depreciation
0
1
4
8
13
13
13
Income Before Tax
-244
-53
-95
-130
-134
-124
-9
Income Tax Expense
-
-
0
0
1
1
0
Net Income
-244
-53
-95
-130
-136
-126
-9
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
88.00%

Century Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-28
-31
-31
-36
76
-32
-34
-19
-21
-34
Operating Cash Flow
-30
-27
-28
-24
-34
-27
-25
-16
-25
-19
Investing Cash Flow
11
-33
39
30
27
32
24
22
-112
17
Financing Cash Flow
18
56
0
0
0
-
-
0
126
0
Change in Cash
0
-4
11
5
-6
4
0
6
-11
-1

Century Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-244
-53
-95
-130
-136
-126
-9
Operating Cash Flow
-16
-41
-89
14
-88
-110
-103
Investing Cash Flow
-19
-22
-298
-13
61
47
107
Financing Cash Flow
74
47
417
27
-9
74
0
Change in Cash
38
-16
30
28
-36
11
3

Global Institutional Holdings in Century Therapeutics

Check out the Institutions with significant holdings in Century Therapeutics.

Funds
Holdings
Peter Kolchinsky
9.80%
Brad Bolzon
6.72%
Vanguard
3.67%
VANGUARD INDEX FUNDS
3.06%
iShares
2.53%

Insights on Century Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IPSC stock has moved up by 231.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 771.0K → 109.16M (in $), with an average increase of 59.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 687.7% return, outperforming this stock by 456.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 97.0% return, outperforming this stock by 114.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -19.17M → -34.54M (in $), with an average decrease of 36.3% per quarter

About Century Therapeutics

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia. CNTY-106: Another multi-specific CAR-iNK or CAR-iT candidate for multiple myeloma. Established in 2018, Century Therapeutics, Inc. is based in Philadelphia, Pennsylvania.
OrganisationCentury Therapeutics
Headquarters25 North 38th Street, Philadelphia, PA, 19104, US
IndustryBiotechnology
CEOBrent Pfeiffenberger

Key Management of Century Therapeutics

Name

Title

Dr. Gregory Russotti Ph.D.

Chief Technology & Manufacturing Officer

Dr. Chad A. Cowan Ph.D.

Chief Scientific Officer

Mr. Douglas Carr CPA

Senior VP of Finance & Operations, Principal Financial Officer and Secretary

Krista Kauppinen J.D., Ph.D.

VP, General Counsel & Head of Intellectual Property

Ms. Megan Bilson

Chief People Officer

Michael Naso Ph.D.

Senior VP of Cell Engineering

Ms. Elizabeth Devlin

VP & Head of Development

Dr. Brent Pfeiffenberger M.B.A., Pharm.D.

President, CEO & Chairman

FAQs

What is Century Therapeutics share price today?

Century Therapeutics share price today is $1.65 as on at the close of the market. Century Therapeutics share today touched a day high of $1.67 and a low of $1.63.

What is the 52 week high and 52 week low for Century Therapeutics share?

Century Therapeutics share touched a 52 week high of $3.04 on and a 52 week low of $0.44 on . Century Therapeutics stock price today i.e. is closed at $1.65,which is 45.72% down from its 52 week high and 279.31% up from its 52 week low.

What is Century Therapeutics's market capitalisation today?

Century Therapeutics market capitalisation is $0.00T as on .

How to invest in Century Therapeutics Stock (IPSC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Century Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Century Therapeutics Stock (IPSC) from India?

Indian investors can start investing in Century Therapeutics (IPSC) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Century Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Century Therapeutics share’s latest price of $1.65 as on September 30, 2026 at 8:45 am IST, you will get 6.0606 shares of Century Therapeutics. Learn more about fractional shares .

What are the returns that Century Therapeutics has given to Indian investors in the last 5 years?

Century Therapeutics stock has given -93.44% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?